Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases

F inancing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and existing investors SCGC and

Kingsware completes C+ Round Financing at nearly RMB 500 million, State-owned Enterprises invest in RPA industry.

Xinhua Silk Road: Sheng Hong Holding Group launches new energy projects in E. China's Zhangjiagang

Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology

SJSemi Signed $340 Million of C+ Financing

Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy

Sihuan Pharmaceutical（0460.HK）: Huisheng Biopharmaceutical Successfully Completed the A + Round of Financing

Accropeutics Secured $12 Million in Series B Plus Financing

Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from

Leading Chinese food chain franchise "Xiaocaiyuan" completes financing with exclusive investment by Harvest Capital